Лечения за Косопад
Разгледайте наличните лечения за косопад. Всички включват преглед от независим лекар от ЕС, оригинални лекарства от лицензирани аптеки и дискретна експресна доставка.
Косопад
Propecia (Finasteride)
Propecia (finasteride 1mg) is an FDA-approved prescription medication for male pattern hair loss (androgenetic alopecia). Clinical studies show it stops hair loss in 90% of men and promotes hair regrowth in approximately 65% of men. Works best for hair loss on the crown and mid-scalp.
Rogaine (Minoxidil)
Minoxidil is a topical treatment used to help regrow hair and slow hair loss. It is available over-the-counter for treating male pattern baldness.
Interested in Косопад?
Complete a confidential health assessment reviewed by an independent EU-registered doctor.
Start AssessmentHair loss treatments in Europe
Hair loss — medically referred to as alopecia — affects a significant proportion of the European population. Androgenetic alopecia, commonly known as male or female pattern baldness, is the most prevalent form. It is estimated that approximately 50% of men experience noticeable hair loss by the age of 50, and female pattern hair loss is also more common than widely recognised, affecting an estimated 40% of women by the age of 70.
Androgenetic alopecia is driven primarily by genetic predisposition and the action of dihydrotestosterone (DHT), a potent androgen derived from testosterone via the enzyme 5-alpha reductase. DHT causes miniaturisation of hair follicles, leading to progressively finer and shorter hair until follicles are no longer productive. The pattern of loss differs between males and females: men typically experience recession at the temples and crown, while women more commonly experience diffuse thinning over the top of the scalp.
The psychological impact of hair loss should not be underestimated. Research published in peer-reviewed journals has consistently documented associations between hair loss and reduced self-esteem, anxiety, and in some cases clinical depression. The availability of effective pharmacological treatments has improved significantly over recent decades, offering meaningful benefit for many patients when treatment is initiated early.
Prescription medications for hair loss work through different mechanisms. Finasteride and dutasteride reduce DHT levels systemically. Minoxidil, available in both topical and oral formulations, acts as a vasodilator that prolongs the growth phase of hair follicles. All treatment decisions should be made by a qualified, independent doctor based on thorough clinical assessment.
Available treatments
The following medications are available for hair loss treatment through EU-registered doctors. This comparison is provided for informational purposes only. A doctor will assess which medication, if any, is appropriate for your individual situation.
| Medication | Active Ingredient | Form | Primary Use | EMA-Approved Indication |
|---|---|---|---|---|
| Finasteride | Finasteride | Oral tablet | Male pattern hair loss | Androgenetic alopecia in men (1 mg) |
| Minoxidil | Minoxidil | Topical solution / foam | Male and female pattern hair loss | Androgenetic alopecia |
| Dutasteride | Dutasteride | Oral capsule | Male pattern hair loss (off-label) | EMA-approved for BPH; off-label for hair loss |
Key distinctions:
- Finasteride: The first-line oral treatment for male androgenetic alopecia. Clinical studies show it can halt progression and promote regrowth in the majority of men. Not appropriate for women of childbearing potential.
- Minoxidil: Available in topical and, increasingly, low-dose oral formulations. Approved for use in both men and women. Effective as monotherapy or in combination with finasteride.
- Dutasteride: Achieves higher DHT suppression than finasteride due to dual enzyme inhibition. Some clinical evidence supports greater efficacy, but it carries an off-label status for hair loss in most EU jurisdictions. A doctor will advise whether it is appropriate for you.
How to get hair loss treatment online
Prescrivia operates as a technology intermediary. We do not prescribe medications, employ doctors, or sell medicines. Our platform connects patients across Europe with independent EU-registered doctors and licensed pharmacies.
The process:
-
Complete a health assessment — Answer a structured set of medical questions covering the pattern and duration of your hair loss, family history, current medications, and relevant medical history. Photos may be requested to support the clinical assessment.
-
Independent doctor review — An independent EU-registered doctor reviews your assessment. If a hair loss medication is clinically appropriate, the doctor may issue a prescription. If it is not appropriate for your circumstances, the doctor will explain the reasoning.
-
Pharmacy fulfilment — If a prescription is issued, it is passed to a licensed EU pharmacy partner. The pharmacy dispenses the medication and arranges delivery directly to your address.
Important: Prescrivia does not guarantee that a prescription will be issued. Prescribing decisions are made entirely by independent medical professionals. Prescription hair loss medications require a valid prescription from a licensed doctor.
How we compare
| Through Prescrivia | In-person GP appointment | |
|---|---|---|
| Availability | 24/7 online assessment | Subject to appointment availability |
| Wait time | Assessment reviewed within hours | Days to weeks depending on location |
| Travel required | No | Yes |
| Prescribing decision | Made by independent EU-registered doctor | Made by your GP |
| Ongoing monitoring | Supported via follow-up assessments | Managed by your GP |
| Cost | Transparent pricing displayed upfront | Varies by country and healthcare system |
Note: Sudden or patchy hair loss, hair loss accompanied by scalp changes, or loss that may be secondary to an underlying medical condition (such as thyroid disease or nutritional deficiency) warrants in-person investigation before treatment. Prescrivia’s platform is designed for adults whose hair loss pattern is consistent with androgenetic alopecia suitable for remote assessment.
Sources
Medical information on this page is based on the following sources:
- European Medicines Agency (EMA). Propecia (finasteride) — Summary of Product Characteristics. Available at: ema.europa.eu
- Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and men. JDDG. 2011;9(S6).
- World Health Organization (WHO). Dermatological conditions — regional data. who.int
This content is reviewed periodically to reflect updated clinical guidance. It is provided for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for advice relevant to your individual health circumstances.
Frequently asked questions
- Can I get hair loss medication online in Europe?
- Yes. Prescrivia connects you with independent EU-registered doctors who can review your health profile and, where clinically appropriate, issue a prescription for hair loss medication. The prescription is then fulfilled by a licensed EU pharmacy and delivered to your address.
- What is the difference between finasteride and dutasteride?
- Both medications work by inhibiting 5-alpha reductase enzymes that convert testosterone to dihydrotestosterone (DHT), the hormone primarily responsible for male pattern hair loss. Finasteride inhibits only the type II enzyme; dutasteride inhibits both type I and type II. Dutasteride achieves greater DHT suppression but is not EMA-approved for hair loss, meaning its use for this indication is off-label.
- Can women use finasteride or minoxidil?
- Finasteride is not generally prescribed for women who may become pregnant due to the risk of harm to a male foetus. Minoxidil, available in lower-concentration formulations, is used to treat female pattern hair loss and is EMA-approved for this indication. A doctor will assess what is appropriate based on your gender, age, and health profile.
- How long does it take to see results from hair loss medication?
- Most clinical evidence indicates that meaningful results from finasteride or minoxidil require consistent use over at least 3 to 6 months. Hair regrowth, where it occurs, is typically gradual. Stopping medication usually results in reversal of benefit over time.
- Are there side effects associated with finasteride?
- Finasteride is associated with sexual side effects in a minority of men, including reduced libido, erectile dysfunction, and ejaculation disorders. These effects are reversible on discontinuation in most cases. The prescribing doctor will discuss risks and benefits based on your individual health profile before issuing a prescription.
Готови ли сте да започнете?
Попълнете поверителна здравна оценка за около 3 минути.